A research team from The University of Osaka has made a significant breakthrough in cancer radiotherapy by identifying ...

A research team from The University of Osaka has made a significant breakthrough in cancer radiotherapy by identifying ...

The global hadron therapy market is on a robust growth trajectory, driven by the surging incidence of cancer and a growing demand for highly targeted, minimally invasive radiation therapies. According ...

Louvain-la-Neuve, Belgium, May 12th, 2025 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the ...

IBA (Ion Beam Applications), the world leader in particle accelerator technology, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency ...

Researchers at the University of Sydney have successfully performed a quantum simulation of chemical dynamics;.

IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of radiopharmaceutical production ...

Sensorion's gene therapy for otoferlin-related hearing loss – a congenital form of deafness – has shown early signs of improving hearing in two toddlers treated in a phase 1/2 trial.